Island Pharma gearing up to start ISLA-101 trial for dengue fever
–News Direct– Island Pharmaceuticals Ltd (ASX:ILA) CEO and managing director Dr David Foster tells Proactive the company is progressing towards a Single Ascending Dose study for its lead asset, ISLA-101, … Read More